The effect of voice therapy on treatment of patients with spasmodic dysphonia after Botox injectio
Not Applicable
- Conditions
- Condition 1: Adductor Spasmodic Dysphonia. Condition 2: Adductor Spasmodic Dysphonia.Other and unspecified voice disturbancesIdiopathic and orofacial dystonia,G 24.4
- Registration Number
- IRCT2016122926499N2
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Inclusion: all patients with adductor Spasmodic Dysphonia; No history of Botox injection
Exclusion: presence of any progressive CNS disorders; Dystonic signs in other part of the body
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Jitter. Timepoint: before intervention, 1-3-6 months after intervention. Method of measurement: Praat software, Hertz.;Fundamental Frequancy. Timepoint: before intervention, 1-3-6 months after intervention. Method of measurement: Praat software, Hertz.;Shimmer. Timepoint: before intervention, 1-3-6 months after intervention. Method of measurement: Praat software, Percent.;Maximum Phonation Time. Timepoint: before intervention, 1-3-6 months after intervention. Method of measurement: Timer, Second.;Perceptual Voice Quality. Timepoint: before intervention, 1-3-6 months after intervention. Method of measurement: GRBAS scale.;Voice Self-assessment score. Timepoint: before intervention, 1-3-6 months after intervention. Method of measurement: Voice Activity and Participation Profile- Persian Version.
- Secondary Outcome Measures
Name Time Method Between Injections intervals. Timepoint: 6 month after intervention. Method of measurement: Month.